Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com


The Global Veterinary Orthopedic Implants Market will Hit $136.8 Million by 2028, at a CAGR of 4.5%

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Veterinary Orthopedic Implants Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Veterinary Orthopedic Implants Market size is expected to reach $136.8 Million by 2028, rising at a market growth of 4.5% CAGR during the forecast period.

The Hospital segment acquired maximum revenue share in the Global Veterinary Orthopedic Implants Market by End User in 2021 thereby, achieving a market value of $63 Million by 2028. The veterinary hospitals have enough funds to get the latest technologies that can decrease the procedure's duration and make the operation pain-free for smaller animals. The quick development of emergency and critical care units in veterinary hospitals and the affordable orthopedic implant services in these hospitals are developing the growth of the veterinary orthopedic implants market.

The Screws segment is showcasing a CAGR of 4.6% during (2022 - 2028). The orthopedic screws can be used for fixation of the bone to bone, soft tissue fixation, or anchorage. There are several variations present in the treatment procedure. The screw system does not disturb the underlying cortical bone perfusion as much as a conventional plate does. The ease and high availability of screw treatments are predicted to surge the development of the veterinary implants market.

The Cruciate Ligament Rupture segment is generating highest revenue share in the Global Veterinary Orthopedic Implants Market by Application in 2021 thereby, achieving a market value of $50.7 Million by 2028. A cruciate ligament rupture is generally painful and the knee joint becomes unstable, which result in lameness. The rising trauma injuries and arthritic diseases in dogs and cruciate rupture in obese dogs are developing the requirement for the orthopedic implant. Thus, the increasing number of overweight dogs is anticipated to propel the development of the veterinary orthopedic implants market.

The North America market dominated the Global Veterinary Orthopedic Implants Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $50.9 Million by 2028. The Europe market is exhibiting a CAGR of 4% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 5.2% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/veterinary-orthopedic-implants-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Vimian Group AB, Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG, Johnson & Johnson, OrthoMed, Inc., Arthrex, Inc., Auxein Medical Pvt. Ltd., Ortho Max Mfg. Co. Pvt. Ltd., BLUESAO Co., Ltd., and Narang Medical Limited.

Global Veterinary Orthopedic Implants Market Segmentation

By End User

  • Hospital
  • Clinics
  • Others

By Product Type

  • Plates
  • Screws
  • Others

By Application

  • Cruciate Ligament Rupture
  • Bone Fractures
  • Hip Dysplasia
  • Elbow Dysplasia
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Vimian Group AB
  • Integra LifeSciences Holdings Corporation
  • B.Braun Melsungen AG
  • Johnson & Johnson
  • OrthoMed, Inc.
  • Arthrex, Inc.
  • Auxein Medical Pvt. Ltd.
  • Ortho Max Mfg. Co. Pvt. Ltd.
  • BLUESAO Co., Ltd.
  • Narang Medical Limited

Related Reports:



SUBSCRIPTION MODEL